Literature DB >> 11855576

Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

W Thierfelder1, W Hellenbrand, H Meisel, E Schreier, R Dortschy.   

Abstract

The prevalence of serological parameters indicative of infection with hepatitis A, B and C was determined using sera collected from representative population samples in the former East German (new) federal states and the West German (old) federal states during the German National Health and Examination Survey in 1998. Sera were tested for antibodies to hepatitis A virus (HAV), to hepatitis B core antigen (HBc) and to hepatitis B surface antigen (HBsAg), hepatitis C Virus (HCV), as well as for the presence of HBsAg and HCV-RNA. The mean weighted prevalence of anti-HAV was 46.5% (95% CI: 45.3-47.7) and increased markedly with age. The mean weighted prevalence of past infection with hepatitis B was 7.7% (95% CI: 7.0-8.4) in the old federal states and 4.3% (95% CI: 3.2-5.3) in the new federal states, corresponding to an overall prevalence of 7.0% (95% CI: 6.4-7.6). The mean weighted prevalence of HBsAg carriage was 0.6% (95% CI: 0.4-0.8), while the prevalence of HCV antibodies was 0.4% (95% CI: 0.2-0.5).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11855576     DOI: 10.1023/a:1013792013184

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  [The German Health Survey. 1997/98].

Authors:  B M Bellach; H Knopf; W Thefeld
Journal:  Gesundheitswesen       Date:  1998-12

2.  Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.

Authors:  K Stark; E Schreier; R Müller; D Wirth; G Driesel; U Bienzle
Journal:  Scand J Infect Dis       Date:  1995

3.  Estimated risk of transmission of hepatitis C virus by blood transfusion.

Authors:  K Koerner; M Cardoso; T Dengler; M Kerowgan; B Kubanek
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

4.  The shift in prevalence of hepatitis A immunity in Flanders, Belgium.

Authors:  M Beutels; P Van Damme; R Vranckx; A Meheus
Journal:  Acta Gastroenterol Belg       Date:  1998 Jan-Mar       Impact factor: 1.316

5.  [High percentage of isolated anti-HBc-positive persons among prisoners].

Authors:  S Neifer; B Molz; U Sucker; E Kreuzpaintner; K Weinberger; W Jilg
Journal:  Gesundheitswesen       Date:  1997-06

6.  Prevalence of hepatitis A antibodies in Swiss travellers.

Authors:  S Studer; H I Joller-Jemelka; R Steffen; P J Grob
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

7.  [Sequelae of imported tropical diseases in Germany].

Authors:  H D Nothdurft; T Löscher
Journal:  Versicherungsmedizin       Date:  1994-08-01

8.  [Prevalence and follow-up of hepatitis C virus infection in pregnancy].

Authors:  P Hillemanns; P Langenegger; B C Langer; R Knitza; U Hasbargen; H Hepp
Journal:  Z Geburtshilfe Neonatol       Date:  1998 May-Jun       Impact factor: 0.685

9.  Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.

Authors:  W M Prodinger; C Larcher; B M Sölder; D Geissler; M P Dierich
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

10.  Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany.

Authors:  B Weber; H Rabenau; A Berger; E H Scheuermann; S Staszewski; W Kreuz; I Scharrer; W Schoeppe; H W Doerr
Journal:  Zentralbl Bakteriol       Date:  1995-01
View more
  19 in total

1.  Outbreak of hepatitis A in two federal states of Germany: bakery products as vehicle of infection.

Authors:  K Schenkel; V Bremer; C Grabe; U Van Treeck; E Schreier; M Höhne; A Ammon; K Alpers
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

2.  Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.

Authors:  J Mossong; L Putz; S Patiny; F Schneider
Journal:  Epidemiol Infect       Date:  2006-01-25       Impact factor: 2.451

3.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Authors:  Filippo Ansaldi; Bianca Bruzzone; Maria Cristina Rota; Antonino Bella; Marta Ciofi degli Atti; Paolo Durando; Roberto Gasparini; Giancarlo Icardi
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

4.  Is the HDV seroprevalence in patients admitted to a university hospital representative for all HBV carriers in Germany?

Authors:  A L Bissinger; C P Berg
Journal:  Infection       Date:  2013-02-24       Impact factor: 3.553

5.  Is there a benefit to a routine preoperative screening of infectivity for HIV, hepatitis B and C virus before elective orthopaedic operations?

Authors:  P Weber; J Eberle; J R Bogner; F Schrimpf; V Jansson; S Huber-Wagner
Journal:  Infection       Date:  2012-12-07       Impact factor: 3.553

6.  Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.

Authors:  A Krumbholz; A Neubert; H Girschick; H I Huppertz; P Kaiser; J Liese; A Streng; T Niehues; J Peters; A Sauerbrey; H Schroten; T Tenenbaum; S Wirth; A Sauerbrei
Journal:  Med Microbiol Immunol       Date:  2013-06-29       Impact factor: 3.402

7.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

Review 8.  [Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?].

Authors:  A Kubitschke; C Bader; H L Tillmann; M P Manns; S Kuhn; H Wedemeyer
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

Review 9.  Hepatitis C virus infection in the elderly: epidemiology, natural history and management.

Authors:  Francesca Cainelli
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Epidemiology of hepatitis A virus infections, Germany, 2007-2008.

Authors:  Mirko S Faber; Klaus Stark; Susanne C Behnke; Eckart Schreier; Christina Frank
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.